• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.32 Up 0.09(2.13%) 4:00PM EST
    |After Hours : 4.32 0.00 (0.00%) 4:40PM EST
    Add to Portfolio
    Prev Close:4.23
    Open:4.23
    Bid:4.30 x 1400
    Ask:4.40 x 1000
    1y Target Est:6.90
    Beta:-4.12
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:4.23 - 4.37
    52wk Range:3.26 - 7.24
    Volume:4,609,923
    Avg Vol (3m):8,779,240
    Market Cap:1.04B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 2.13%1.04B
    GSKDown 1.83%112.41B
    OREXDown 11.36%878.46M
    RHHBYUp 0.47%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):27.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.50
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback